CLINICAL TRIALS PROFILE FOR LORTAB
✉ Email this page to a colleague
All Clinical Trials for Lortab
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00174538 ↗ | Codeine in Sickle Cell Disease | Completed | PriCara, Unit of Ortho-McNeil, Inc. | Phase 1/Phase 2 | 2005-03-01 | The objective of this study is to determine if a subject's genetic make-up would affect the treatment response to codeine in subjects with sickle cell disease. |
| NCT00385684 ↗ | Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT) | Completed | VA Office of Research and Development | Phase 4 | 2007-10-01 | The purpose of this study was to determine whether a low dose an opiate pain medication is effective for the treatment of discomfort in patients with advanced dementia. The study medication was also known as Lortab and contained both a narcotic pain medication and acetaminophen (the same pain medication as contained in Tylenol). This study was an eight-week long clinical trial for discomfort among veterans with advanced dementia who were admitted to a Nursing Home Care Unit (NHCU) at the Tuscaloosa VA Medical Center. |
| NCT00574015 ↗ | The Comparison of Supraperiosteal Nerve Block With Opiate Analgesia in Alleviating the Pain of Toothache | Completed | Albany Medical College | Phase 4 | 2007-12-01 | This study will compare the degree of pain control provided by two techniques for persons with toothache in an emergency department. The two techniques include; - standard oral narcotic pain medication - numbing the tooth with local anesthetic by needle injection |
| NCT00583453 ↗ | Celecoxib as a Post-tonsillectomy Pain Medication | Completed | Pfizer | Phase 2 | 2007-10-01 | The hypothesis is that celecoxib effectively reduces pain after a tonsillectomy and reduces post-operative narcotic use. To test this hypothesis, the study is placebo controlled (sugar pill). Half of the participants will receive a sugar pill, half will not. All participants will receive the standard post-operative pain medications. We ask participants to log the amount of medications they use daily, and the amount of pain they have each day. It is hoped that celecoxib will reduce the amount of post-operative pain medication needed. |
| NCT00583453 ↗ | Celecoxib as a Post-tonsillectomy Pain Medication | Completed | University of Iowa | Phase 2 | 2007-10-01 | The hypothesis is that celecoxib effectively reduces pain after a tonsillectomy and reduces post-operative narcotic use. To test this hypothesis, the study is placebo controlled (sugar pill). Half of the participants will receive a sugar pill, half will not. All participants will receive the standard post-operative pain medications. We ask participants to log the amount of medications they use daily, and the amount of pain they have each day. It is hoped that celecoxib will reduce the amount of post-operative pain medication needed. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Lortab
Condition Name
Clinical Trial Locations for Lortab
Trials by Country
Clinical Trial Progress for Lortab
Clinical Trial Phase
Clinical Trial Sponsors for Lortab
Sponsor Name
